A new medical development is sweeping the country…
Some may see it as controversial – but the studies don’t lie.
So effective, in fact, that the FDA has just fast-tracked its approval…
Meaning that it is poised to gain a major stake in a key healthcare market that is on track to hit $260 billion in the next six years.
And one company, in particular, is making all the right moves.
In the last 13 months, Champignon Brands (CN:SHRM;OTC:SHRMF) has taken a potential wonder drug from concept to product production for research. It then went public as a company and gained controlling ownership of a leading medical treatment clinic.
The name of this potential wonder drug is psilocybin, a natural psychedelic compound found in mushrooms, and it